BRIPALO Trademark

Trademark Overview

On Wednesday, November 8, 2017, a trademark application was filed for BRIPALO with the United States Patent and Trademark Office. The USPTO has given the BRIPALO trademark a serial number of 87676793. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 27, 2021. This trademark is owned by Bristol-Myers Squibb Company. The BRIPALO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
bripalo

General Information

Serial Number87676793
Word MarkBRIPALO
Filing DateWednesday, November 8, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 27, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 25, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, November 18, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, December 27, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 27, 2021ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 6, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 5, 2021EXTENSION 5 GRANTED
Friday, April 23, 2021EXTENSION 5 FILED
Wednesday, May 5, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, April 23, 2021TEAS EXTENSION RECEIVED
Friday, November 13, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 11, 2020EXTENSION 4 GRANTED
Wednesday, November 11, 2020EXTENSION 4 FILED
Wednesday, November 11, 2020TEAS EXTENSION RECEIVED
Friday, May 15, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 13, 2020EXTENSION 3 GRANTED
Wednesday, May 13, 2020EXTENSION 3 FILED
Wednesday, May 13, 2020TEAS EXTENSION RECEIVED
Saturday, November 2, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 31, 2019EXTENSION 2 GRANTED
Thursday, October 31, 2019EXTENSION 2 FILED
Thursday, October 31, 2019TEAS EXTENSION RECEIVED
Wednesday, May 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2019EXTENSION 1 GRANTED
Monday, May 6, 2019EXTENSION 1 FILED
Monday, May 6, 2019TEAS EXTENSION RECEIVED
Tuesday, November 20, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 25, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 25, 2018PUBLISHED FOR OPPOSITION
Wednesday, September 5, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018ASSIGNED TO LIE
Thursday, August 9, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 7, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2018NON-FINAL ACTION E-MAILED
Wednesday, February 7, 2018NON-FINAL ACTION WRITTEN
Wednesday, January 31, 2018ASSIGNED TO EXAMINER
Saturday, November 18, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, November 11, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

bripalo diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection